Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04530981
Title A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.